|
0
|
|
Nirmatrelvir for acute COVID-19 to prevent long COVID (PANORAMIC Norway): a double-blind, randomised, placebo-controlled trial.
(linkinghub.elsevier.com)
|
Oppegaard O
…
Langeland N
Lancet Infectious Diseases
2026-07-16
|
#covid-19
#clinical trial
#antiviral
#post-viral
|
|
0
|
|
Safety, pharmacokinetics, and antimalarial efficacy of single-dose cabamiquine-pyronaridine combination therapy for the treatment of adults and adolescents with acute uncomplicated Plasmodium falciparum malaria (CAPTURE 1): a prospective, multicentre, open-label, phase 2a study.
(linkinghub.elsevier.com)
|
Mombo-Ngoma G
…
Okebe J
Lancet Infectious Diseases
2026-07-16
|
#malaria
#pharmacokinetics
#clinical trial
#antimalarials
#amr
|
|
0
|
|
Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trial.
(nature.com)
|
Hutchings M
…
Morschhauser F
Nature Medicine
2026-07-16
|
#lymphoma
#clinical trial
#immunotherapy
#bispecific-antibodies
|
|
0
|
|
International consensus on intestinal epithelial barrier assessment and therapeutic effects in inflammatory bowel diseases clinical trials.
(gut.bmj.com)
|
Vieujean S
…
Peyrin-Biroulet L
Gut
2026-07-16
|
#inflammatory-bowel-disease
#clinical trial
#barrier function
#therapeutics
#consensus
|